Elsevier,
Theriogenology Wild, Volume 3, 2023, 100050
Humpback whales (Megaptera novaeangliae) in Southeast Alaska have been studied for over 50 years, and are largely considered a recovery success since the cessation of commercial whaling. To further sustain this success we need to improve our knowledge of how these giants reproduce. The authors developed an effective strategy for monitoring the hormone levels in a challenging natural environment.
Elsevier, Heliyon, Volume 9, August 2023
Mango fruits are a rich source of nutrients, however, due to their perishability and seasonality, minimal processing and drying offer the potential ensure a shelf stable and safe product. The use of sodium metabisulphite (SMB) as pre-treatment in the dried fruit industry has been widely adopted, but sulphite residue remains a health public concern. Therefore, this study investigated the effects of alkaline and acidic electrolyzed water (AIEW and AEW, mg/mL) as alternative pre-treatments to SMB (1% w/w) for ‘Tommy Atkins’ mango slices prior to hot air drying at 60 °C.
Elsevier,
The Lancet Global Health, Volume 11, August 2023
This Health Policy paper supports SDGs 3, 15, and 17, among others, by exploring the potential values and risks of establishing an Intergovernmental Panel for One Health (IPOH), with the aim of contributing to addressing other global challenges, such as food and water safety and environmental degradation in the context of One Health.
Elsevier,
eBioMedicine, Volume 94, August 2023
This Article supports Sustainable Development Goal 3 by identifying an independent relationship between anxiety and subsequent cognitive progression in older people without dementia; these findings suggest that treating anxiety and targeting mitochondrial dysfunction may be effective in preventing dementia.
Elsevier,
eBioMedicine, Volume 94, August 2023
This Article supports Sustainable Development Goal 3 by advancing our understanding of the possible role of active immunotherapy against amyloid-β in individuals with mild Alzheimer's disease; the findings of this phase 2a study support the continued clinical development of UB-311 as an active immunotherapy for Alzheimer's disease.
